“Impact of Sars-CoV-2 Prophylaxis With Tixagevimab-Cilgavimab in High-Risk Patients With B-Cell Malignancies: A Single-Center Retrospective Study”. Mediterranean Journal of Hematology and Infectious Diseases 15, no. 1 (October 30, 2023): e2023061. Accessed April 30, 2026. https://www.mjhid.org/mjhid/article/view/5415.